QUICK SUMMARY
Not every published essential oil study deserves equal weight. A paper can be peer-reviewed and still use the wrong plant preparation, fail to identify the oil properly, test an unrealistic dose, rely only on cells or animals, use a weak control, or draw a conclusion that reaches beyond the actual results.
The fastest way to evaluate essential oil science is to ask: What exactly was tested? Was it a true essential oil, an extract, or an isolated constituent? Which species, plant part, chemotype, and extraction method were used? What was the route, dose, duration, comparison group, and outcome? Was the research done in humans, animals, or cells?
Those questions matter in three long-running debates examined below. Current evidence supports the original concern that boswellic acids should not be treated as normal volatile constituents of steam-distilled frankincense oil, does not establish that lavender or tea tree oil causes breast growth in children, and shows why one negative rosemary-and-lavender attention study cannot be used to claim that those oils simply “do not work.”
As a public health researcher, I'd be remiss to say that every study in the medical literature represents accurate data, and essential oil science is no exception. Sometimes the studies have to be studied!
Somehow, researchers with poorly designed studies, incomplete reporting, questionable assumptions, or conclusions that reach beyond their data get articles published by reputable and sometimes not-so-reputable journals. Then those conclusions spread through the blogosphere and social media until a limitation becomes a headline and a hypothesis becomes a “fact.”
This is not a problem unique to essential oils.
A 2026 systematic review of 133 research-on-research studies found that “spin,” meaning presentation that makes findings appear stronger or more favorable than the data justify, was common in abstracts and full texts across medical research. (1) Essential oil research has its own reporting problems as well. In 2024, an international group of aromatherapy researchers developed the 38-item TREATS checklist because published human aromatherapy studies often fail to report enough detail for replication and practical application. (2)
So yes, read the research. I certainly do. But don't outsource your discernment to the words “peer reviewed.”
In my own review of thousands of papers over the years, I have often seen weak or mismatched evidence used to downplay therapeutic effects just as I have seen preliminary findings exaggerated into claims the study never proved. Both errors matter.
The goal of this article is not to defend every positive essential oil claim or attack every negative paper. It is to help you read the literature accurately.
Table of Contents
Examining Essential Oil Studies
Out of the thousands of peer-reviewed studies I have examined, I have observed that many studies misrepresenting essential oils did so to downplay their therapeutic effect(s), not inflate them to sensationalize some unsubstantiated healing claim. However, there are always exceptions to the rule, and I'll begin with the most well-known one: boswellic acids in frankincense essential oil.
This post, therefore, is an attempt at:
- Busting common essential oil myths that are repeated as though the scientific evidence were settled.
- Itemizing a growing collection of essential oil studies that deserve closer scrutiny.
- Providing logical, evidence-based rebuttals when conclusions or popular interpretations do not match what was actually tested.
- Helping clear up confusion online and creating a more trustworthy approach to essential oil science for bloggers, families, researchers, and healthcare practitioners.
Please note that this article is not static. It's a growing collection of research examples and tips on how to sniff out problems as the literature changes.
That last part is important. Good science is self-correcting. New studies can strengthen an older conclusion, qualify it, or reveal that we were asking the wrong question.
Research on essential oils is also becoming more sophisticated. In 2025, investigators began an international Delphi process to establish consensus reporting criteria specifically for human aromatherapy studies. The proposed criteria cover the study product, essential-oil identity, intervention process, safety, sustainability, olfactory function, and aroma preference. (3)
In other words, the research community itself recognizes a problem we have been talking about for years: if a study does not tell you exactly what oil was used and how it was used, reproducing the result can be impossible.
Direct Answer: What Makes an Essential Oil Study Trustworthy?
A trustworthy essential oil study clearly identifies the oil, botanical species, plant part, extraction method, chemical profile when relevant, route, dose or concentration, duration, population, comparison group, measured outcome, adverse events, funding, and conflicts of interest.
Then ask whether the conclusion matches the experiment. A cell study can establish a laboratory effect. An animal study can provide preclinical evidence. A human trial can test a specific clinical outcome. None automatically proves the next level.
Sniffing Out Poor Studies
Whether or not you are a novice EO user or an advanced practitioner in essential oil therapy, it's important that you tread the medical literature lightly, or else you could be found guilty of spreading essential oil myths or providing dangerous, ineffective advice!
Why?
Because published research studies that discuss therapeutic effects and safety concerns can be misleading when important details are missing or the results are interpreted outside their proper context. This has caused countless well-intentioned bloggers and healthcare practitioners to fall down a slippery slope when discussing scientific evidence found on PubMed.
I'll confess, I was one of those novice essential oil researchers not too long ago. Thankfully, some friendly aromatherapists, like the founder of the Atlantic Institute of Aromatherapy, Sylla Sheppard-Hanger, went out of their way to notify me of my mistakes.
I quickly realized that my public health background didn't cut it and that I needed more formal training in aromatherapy to ensure that I accurately reported the truth about essential oil research in my interviews, articles, and books.
Since then, I've edited, and continue to update, my articles and books. I will not stop as my understanding develops and essential oil science peels off layer by layer of this all-too-mysterious healing art.
NOT ALL STUDIES ARE CREATED EQUAL. So how do you sniff out weak essential oil research?
Unfortunately, it's not an easy answer. It requires an understanding of essential oil chemistry and research concepts such as epidemiology, biostatistics, study design, bias, and clinical relevance to become truly good at it.
Instead of telling you to “leave it to the pros,” I'd rather empower you to DIY with some trusty tips. But be careful. You can get yourself in trouble quickly, and there are serious safety and therapeutic ramifications if you use these precious plant-based compounds incorrectly.
To help you on your journey, here are six guidelines to remember:
1. Extracts Are NOT Essential Oils
Unlike essential oils, extracts can contain both volatile and non-volatile components. The chemical constituency and, therefore, the safety considerations and therapeutic effects can be quite different.
A steam-distilled essential oil is primarily a complex mixture of volatile compounds. A methanol extract, ethanol extract, water extract, CO2 extract, oleoresin, tincture, and whole herb are different preparations.
Current chemistry reviews define essential oils as volatile, lipophilic mixtures produced by methods such as steam or water distillation or, for many citrus oils, mechanical expression. Their constituents are generally low-molecular-weight compounds. (4)
Because of translation problems, inconsistent terminology, or simple imprecision, some papers use words like “extract,” “oil,” and “essential oil” too loosely.
Always go to the Methods section and ask: How did the researchers actually make the material they tested?
2. Isolated Chemical Constituents Are NOT Complete Essential Oils
Putting things into context is important.
Far too many discussions draw therapeutic or safety conclusions about an entire oil from experiments performed with one chemical constituent.
Yes, the chemicals that make up an essential oil can determine safety and therapeutic efficacy to a large degree. Cinnamaldehyde tells us a lot about cinnamon bark oil. Carvacrol tells us a lot about many oregano oils. Linalool and linalyl acetate help us understand lavender.
But an essential oil is a mixture.
Some oils contain dozens of measurable compounds, and minor constituents may modify the effect of major compounds through additive, synergistic, or antagonistic interactions. (4)
So if a paper tested pure linalool, say “linalool.” If it tested isolated beta-elemene, say “beta-elemene.” Do not silently upgrade that finding into proof about lavender, frankincense, or another complete oil.
3. Human Research Is Growing, But Evidence Type Still Matters
When this article was first written, it was fair to say that human essential-oil studies were rare compared with the mountain of cell and animal research.
Human research has grown substantially. We now have randomized trials, systematic reviews, and clinical studies across sleep, anxiety, pain, nausea, cognition, oral health, and other areas.
But in many disease-focused areas, especially cancer, antimicrobial treatment, metabolic disease, and neurodegeneration, much of the mechanistic evidence remains preclinical.
This is not to invalidate laboratory and animal studies. They are how science discovers mechanisms and identifies treatments worth testing in people.
The problem comes when someone writes:
- “This oil killed cancer cells, so it treats cancer in people.”
- “This constituent lowered glucose in diabetic rats, so take these drops for diabetes.”
- “This chemical activated an estrogen receptor in a cell assay, so the complete oil causes hormonal disease in children.”
Those are leaps, not conclusions.
Name the model immediately: human trial, observational human study, animal model, cell experiment, or isolated constituent study.
4. Abstracts Can Be Misleading
This is a tough one for people to understand, but an abstract is not a research study. It's a snapshot and often lacks key data points and contextual information.
The solution is to read the entire article whenever the claim matters.
That advice has only become more important. A 2026 systematic review found that spin was present in about 59% of randomized-trial abstracts and roughly half of systematic-review abstracts across the medical literature included in the analysis. (1)
“Spin” does not necessarily mean fraud. It can mean emphasizing a secondary positive finding when the primary outcome failed, using stronger causal language than the study design permits, minimizing adverse results, or making the conclusion sound more clinically important than the data support.
If you cannot access the full article, do not build a strong medical recommendation on the abstract alone.
5. Research and Researchers Are Not Infallible
Just because something is peer-reviewed doesn't mean it's 100% correct.
Researchers are people. Editors are people. Peer reviewers are people. Mistakes, questionable assumptions, missing data, statistical errors, weak controls, selective reporting, and overinterpretation can survive peer review.
Essential-oil investigators face an additional challenge: the intervention itself must be reported well enough to reproduce it.
The 2024 TREATS project was created because human aromatherapy studies frequently omitted important essential-oil and intervention details needed for replication. (2)
Look for:
- Botanical name and plant part
- Extraction method
- Chemotype or chemical analysis when it affects the question
- Supplier and batch information when relevant
- Route of administration
- Actual concentration or dose
- Length and frequency of exposure
- Control or comparator
- Participant scent preference or ability to smell when studying inhalation
- Adverse-event reporting
If you do not know what the participants received, how much they received, or whether they were actually exposed to the aroma as intended, the paper may still be interesting, but its practical value drops fast.
6. Check Funding, Conflicts, and Author Assumptions
Do a quick search of the authors and read the funding and conflict-of-interest statements.
PubMed often displays conflict statements supplied by journals, but it is not a magic bias detector. A disclosure tells you about a known relationship. It does not tell you whether the study is wrong, and the absence of a disclosure does not prove the absence of bias.
Industry funding is not automatic evidence that a study should be rejected. Academic, government, nonprofit, advocacy, and professional communities can have their own assumptions as well.
What matters is whether the study design protects the data from those assumptions.
There is good reason to pay attention. A Cochrane review of drug and device research found that industry-sponsored studies were more likely to report sponsor-favorable results and conclusions than studies with other sponsorship. (5)
So check the money, but also check the methods. A well-designed study does not become false because a company funded it, and a poorly designed study does not become trustworthy because nobody made money from it.
Debunking 3 Common Essential Oil Research Myths
Remember, this is a growing collection. The point is not merely to label a study “good” or “bad.” The more useful question is: What does this study actually allow us to conclude?
The three examples below are especially helpful because each exposes a different research problem:
- Confusing a non-volatile resin constituent with the distilled essential oil
- Turning case reports and cell assays into a causal human safety claim
- Turning one negative experiment into a sweeping statement that an oil “doesn't work”
1. Boswellic Acids in Frankincense Oil
Article Title: Boswellia sacra essential oil induces tumor cell-specific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cells.
The 2011 study reported that higher-temperature hydrodistillation fractions contained more high-molecular-weight compounds, including boswellic acids, and that the preparations reduced viability in cultured breast cancer cells. (6)
This was a tricky one for me.
When I first started reporting on essential oils, I was assigned the task of discussing how frankincense essential oil could possibly attenuate cancer cells. Being the public health researcher that I am, I followed my normal course of action and conducted a thorough literature review.
When these papers came up, I took their terminology at face value.
DON'T BE FOOLED. Not being a chemist, I was initially misled by this research and reported it before I understood the chemistry problem.
Here's the problem.
Boswellic acids are pentacyclic triterpenes found in frankincense resin. They are non-volatile resin constituents. Essential oils, by contrast, are the volatile fraction recovered through distillation or expression.
Modern essential-oil chemistry references generally describe typical essential-oil constituents as low-molecular-weight volatile compounds, commonly under approximately 300 Da. (4) Boswellic acids are much larger, non-volatile molecules.
That means we should not casually describe boswellic acids as normal constituents that “distill over” into frankincense essential oil.
If a hydrodistillation preparation contains detectable boswellic acids or other high-molecular-weight resin material, a more plausible explanation is mechanical carryover, splashing, entrainment, unusual processing, or a preparation that is not chemically equivalent to a conventional clean volatile distillate.
That distinction matters because frankincense essential oil is widely discussed for anticancer potential, and a myth developed that its effects must come from boswellic acids.
If you're specifically trying to obtain boswellic acids, Boswellia resin extracts and standardized supplements are the relevant preparations, not ordinary steam-distilled frankincense essential oil.
So Does Frankincense Essential Oil Have Anticancer Potential?
Yes, the preclinical question remains very much alive. But boswellic acids are not required to explain it.
The original 2009 Boswellia carteri paper found selective cytotoxicity in cultured bladder cancer cells. (7) The 2014 bladder-cancer study reported different gene-expression responses to frankincense and sandalwood oils. (8)
And this field did not stop in 2014.
A 2025 study used GC/MS to identify 48 components in a commercial Boswellia carterii essential oil, with alpha-pinene as the major constituent at 35.81%. Researchers observed anticancer effects in breast-cancer cell lines and a mouse mammary-carcinoma model. This is stronger preclinical evidence than a cell dish alone, but it is still not a human cancer trial. (9)
That is the evidence-matched conclusion today:
Frankincense essential oil has demonstrated anticancer activity in laboratory and animal research, but it has not been proven to treat cancer in humans, and its potential activity should not be attributed to boswellic acids in ordinary distilled oil.
Beta-elemene is another anticancer terpene sometimes discussed in this conversation, and it occurs in some aromatic oils and plant preparations, including some myrrh oils. We have also discussed natural cancer-support strategies in Beating Cancer God's Way. But frankincense species and batches vary greatly, so beta-elemene should not be treated as the universal explanation for frankincense's effects either.
At the end of the day, once we know the basic properties of an herb, root, resin, extract, and essential oil, we can determine the best ways to utilize each one without confusing them.
2. Lavender Causes Breast Growth in Boys
Article Title: Prepubertal Gynecomastia Linked to Lavender and Tea Tree Oils.
The original 2007 report described three boys with prepubertal gynecomastia who had used topical products containing lavender and/or tea tree oil. The breast tissue regressed after the products were discontinued, and laboratory experiments reported weak estrogenic and antiandrogenic activity. (10)
The long and the short of it is that three boys developed uncommon cases of prepubertal breast enlargement for a period of time while using products such as shampoo, lotion, soap, or balm that reportedly included lavender essential oil or Melaleuca alternifolia (tea tree) oil.
Researchers suspected the oils based on the case histories and in vitro receptor assays.
The key word is suspected.
Case reports are valuable for identifying safety signals. They are not designed to prove causation.
The products contained multiple ingredients. Actual concentrations and absorbed doses were uncertain. The conditions can regress spontaneously. Other environmental, dietary, developmental, medication, and product exposures could not be fully ruled out.
This is a classic epidemiological lesson: correlation does not automatically establish causation.
What Has Research Since 2007 Found?
The evidence is much fuller today than when this article was first written.
A 2013 uterotrophic assay applied lavender oil to immature female rats at 20 or 100 mg/kg per day for three days and found no evidence of estrogenic activity based on uterine weights. (11)
A 2019 paper added three girls and one boy with breast development associated with continuous exposure to lavender-fragranced products and found estrogenic or antiandrogenic activity from several essential-oil constituents in human cell assays. Importantly, the authors themselves stated that whether lavender's potency was sufficient to cause the clinical effects was unknown. (12)
A 2020 systematic review found no evidence supporting a tea-tree-oil link to pediatric endocrine disruption and little to no clinical evidence substantiating the proposed lavender link. (13)
Then came the epidemiological evidence the debate had been missing.
A cross-sectional study of 556 children ages 2-15 found no cases of prepubertal gynecomastia in either the exposed or unexposed groups and no statistically significant difference in total endocrine-disorder risk between children regularly exposed to lavender or tea tree products and those who were not. (14)
A 2023 review of the reported cases concluded that topical lavender and/or tea tree use cannot be established as the cause because exposure details are limited, dermal absorption matters, other agents were not adequately excluded, and spontaneous regression can occur. (15)
And in 2024, investigators tested linalool and linalyl acetate, two major lavender constituents, through a series of modern guideline-based in vitro and in vivo endocrine assays. The initial concerns were not confirmed. (16)
So what can we responsibly say today?
The claim that lavender or tea tree essential oil has been proven to cause breast growth or endocrine disruption in children is not supported by the current clinical and epidemiological evidence.
At the same time, science does not require us to pretend the earlier case reports and cell assays never happened. They created a legitimate safety question. Later studies have simply given us better evidence for interpreting that question.
This is exactly how science should work.
3. Lavender & Rosemary Oil “Don't Work”
Article Title: No effects of rosemary and lavender essential oil and a placebo pill on sustained attention, alertness, and heart rate.
This one is a doozy, and I'll try to be nice.
The 2017 study randomized 128 young adults to rosemary aroma, lavender aroma, a stimulant-suggestion placebo pill, or a no-treatment control. Researchers found no differences among the interventions in actual sustained-attention changes, self-rated alertness, or heart rate. (17)
The paper is useful evidence for that specific experiment.
It is not evidence that lavender and rosemary “don't work.”
That distinction sounds obvious, but it is exactly where research headlines get us into trouble.
Problem 1: The Outcome Was Narrow
The researchers measured sustained attention, perceived alertness, and heart rate over a particular exposure period.
Lavender is usually studied for outcomes such as relaxation, anxiety, sleep, pain, or stress, not as a stimulant expected to enhance vigilance.
Rosemary has been investigated for cognition and alertness, but a null result on one sustained-attention task does not erase other cognitive outcomes.
Problem 2: Expectation Was Part of the Experiment
The study intentionally included a placebo pill paired with a suggestion that it contained rapidly absorbed herbal substances that could improve alertness.
That makes the paper interesting for understanding expectancy effects. It also means we should not reduce it to “essential oils failed.”
In fact, the same research group had previously shown that expectations can influence subjective responses to lavender, rosemary, and eucalyptus aromas. (18)
Expectation is not an embarrassing contaminant unique to natural medicine. It is part of the human response to treatment and one reason careful controls matter.
Problem 3: Dose and Exposure Matter
The original study used a defined environmental spray exposure rather than a typical personal inhaler or diffuser protocol.
This is where I continue to push researchers: “Could the participants smell it?” is not the same question as “Did the intervention produce a therapeutically meaningful exposure?”
For inhalation research we need to know:
- Exactly which oil was used
- How much oil entered the space or device
- Room volume and ventilation
- Distance from the source
- Duration and frequency of exposure
- Whether olfactory function was tested
- Whether participants liked or disliked the aroma
- Whether the chemical composition of the oil was documented
These are precisely the kinds of reporting details modern aromatherapy researchers are now trying to standardize. (2, 3)
What Does the Rest of the Rosemary and Lavender Research Say?
Long before the 2017 null study, a randomized experiment in 144 healthy adults found that rosemary and lavender aromas produced different effects on cognition and mood. Rosemary was associated with better performance on some memory outcomes, while lavender produced a different, more sedating cognitive pattern. (19)
In a 2012 rosemary study, researchers measured blood levels of absorbed 1,8-cineole after inhalation. Higher plasma 1,8-cineole concentrations correlated with better speed and accuracy on cognitive tasks. This was a small study of 20 healthy adults, so it provides mechanistic human evidence rather than definitive proof of a clinical treatment. (20)
More recently, a 2024 controlled study in older adults with diabetes reported improvements in cognitive function, anxiety, and sleep quality after lavender or rosemary inhalation protocols. The population and outcomes were very different from the 2017 vigilance experiment, which is exactly the point. (21)
This does not mean every rosemary or lavender study will be positive.
It means one negative study can only answer the question it actually tested.
That's the larger lesson of this entire article.
Essential Oil Science FAQs
Is PubMed proof that an essential oil claim is true?
No. PubMed is a database that helps you locate biomedical literature. Inclusion in PubMed does not mean the National Library of Medicine has independently verified every conclusion. You still need to evaluate the study design, methods, statistics, preparation, population, and evidence level.
Are peer-reviewed essential oil studies reliable?
Peer review is valuable, but it is a quality-control process, not a guarantee of truth. A peer-reviewed paper can still have weak controls, inadequate sample size, missing intervention details, statistical problems, or conclusions that reach beyond the results.
What is the biggest mistake people make when citing essential oil research?
One of the biggest mistakes is citing research on a whole herb, extract, or isolated constituent as though it tested the essential oil. The exact preparation matters because different preparations contain different chemicals at different concentrations.
Can animal and cell studies tell us anything useful?
Absolutely. They can identify mechanisms, biological activity, toxicology signals, and promising therapies worth testing in humans. What they cannot do is establish human clinical efficacy or justify a human dose by themselves.
Why does essential oil dosage matter in a study?
The route, concentration, amount, exposure time, and frequency determine what reaches the body. A brief room exposure is not equivalent to a personal inhaler. A 0.1% topical product is not equivalent to neat application. A culinary amount in a full recipe is not equivalent to a medicinal internal protocol.
Does frankincense essential oil contain boswellic acid?
Boswellic acids are non-volatile triterpenes of frankincense resin and are not expected to be normal constituents of a clean steam-distilled essential oil. Reports of boswellic acids in unusual hydrodistillates should be interpreted in light of possible mechanical carryover or processing differences. If the goal is boswellic acid, a standardized Boswellia resin extract is the relevant preparation.
Does frankincense essential oil kill cancer?
Frankincense essential oil has demonstrated anticancer activity in cultured cancer cells and animal models, including newer 2025 preclinical research. That is meaningful research, but it does not establish frankincense essential oil as a proven human cancer treatment. (9)
Does lavender cause gynecomastia in boys?
Current evidence does not establish that lavender essential oil causes prepubertal gynecomastia. Case reports and cell assays raised the question, but a systematic review, a study of 556 children, a later evidence review, and guideline-based testing of major lavender constituents have not confirmed the causal claim. (13, 14, 15, 16)
Do lavender and rosemary essential oils work for cognition?
The answer depends on the oil, dose, person, outcome, and protocol. Some human studies report cognitive or mood effects, while others report no effect on specific outcomes. The evidence does not support the blanket statement that either oil always improves cognition, nor does it support the blanket statement that they “don't work.”
How should bloggers cite essential oil science responsibly?
Name what was actually studied and the evidence type. Say “a laboratory study of carvacrol” instead of “oregano oil cures.” Say “a mouse study found” instead of “research proves in people.” Link to the original paper whenever possible and read the Methods and Results before repeating the abstract conclusion.
What should I look for in a human inhalation study?
Look for botanical identity, oil chemistry, dose, delivery method, room size, ventilation, duration, frequency, scent preference, olfactory ability, blinding strategy, comparator, outcomes, adverse events, and enough detail to reproduce the intervention.
Should conflicts of interest make me reject a study?
No. A conflict is information to consider, not an automatic disqualification. Examine whether the design, analysis, data reporting, and conclusions are sound. Apply the same scrutiny when a study confirms what you already believe.
Have you found an essential oil study that doesn't seem to match its headline or conclusion? The best way to handle it is to pull the full paper, identify exactly what was tested, and walk through the evidence one layer at a time.
That is how we protect the credibility of natural health research without weakening what good essential oil science actually shows.
- Su N, van der Linden M, van der Heijden G, Listl S, Faggion CM Jr. “Moderate to High Prevalence of Spin Revealed in Abstracts and Main Texts of Medical Publications: A Systematic Review of Research-on-Research Studies.” Journal of Clinical Epidemiology. 2026;195:112264. Source.
- Reven ME, Bowles EJ, Audia DD, Cohen MM, Joswiak DJ, Kurkas Lee BA, et al. “Quality Appraisal of Research Reporting for Aromatherapy and Essential Oil Studies in Humans: Proposed Checklist for Transparent Reporting for Essential Oil and Aroma Therapeutic Studies.” Journal of Integrative and Complementary Medicine. 2024;30(5):469-477. Source.
- Reven ME, Bowles EJ, Ablard K, et al. “Essential Criteria for Reporting of Aromatherapy-Focused Research in Humans: An International Delphi Consensus Study Protocol.” PLOS ONE. 2025;20(3):e0318379. Source.
- de Sousa DP, Silva RHN, Silva EF, et al. “Essential Oils: Chemistry and Pharmacological Activities.” Biomolecules. 2023;13(7):1144. Source.
- Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L. “Industry Sponsorship and Research Outcome.” Cochrane Database of Systematic Reviews. 2017;2:MR000033. Source.
- Suhail MM, Wu W, Cao A, et al. “Boswellia sacra Essential Oil Induces Tumor Cell-Specific Apoptosis and Suppresses Tumor Aggressiveness in Cultured Human Breast Cancer Cells.” BMC Complementary and Alternative Medicine. 2011;11:129. Source.
- Frank MB, Yang Q, Osban J, et al. “Frankincense Oil Derived from Boswellia carteri Induces Tumor Cell Specific Cytotoxicity.” BMC Complementary and Alternative Medicine. 2009;9:6. Source.
- Dozmorov MG, Yang Q, Wu W, et al. “Differential Effects of Selective Frankincense (Ru Xiang) Essential Oil Versus Non-Selective Sandalwood (Tan Xiang) Essential Oil on Cultured Bladder Cancer Cells: A Microarray and Bioinformatics Study.” Chinese Medicine. 2014;9:18. Source.
- Mohamed N, Ismail H, Nasr GM, Abdel-Ghany S, Arneth B, Sabit H. “Anti-Tumor Potential of Frankincense Essential Oil and Its Nano-Formulation in Breast Cancer: An In Vivo and In Vitro Study.” Pharmaceutics. 2025;17(4):426. Source.
- Henley DV, Lipson N, Korach KS, Bloch CA. “Prepubertal Gynecomastia Linked to Lavender and Tea Tree Oils.” New England Journal of Medicine. 2007;356(5):479-485. Source.
- Politano VT, McGinty D, Lewis EM, et al. “Uterotrophic Assay of Percutaneous Lavender Oil in Immature Female Rats.” International Journal of Toxicology. 2013;32(2):123-129. Source.
- Ramsey JT, Li Y, Arao Y, et al. “Lavender Products Associated With Premature Thelarche and Prepubertal Gynecomastia: Case Reports and Endocrine-Disrupting Chemical Activities.” Journal of Clinical Endocrinology & Metabolism. 2019;104(11):5393-5405. Source.
- Hawkins J, Hires C, Dunne E, Baker C. “The Relationship Between Lavender and Tea Tree Essential Oils and Pediatric Endocrine Disorders: A Systematic Review of the Literature.” Complementary Therapies in Medicine. 2020;49:102288. Source.
- Hawkins J, Hires C, Dunne E, Keenan L. “Prevalence of Endocrine Disorders Among Children Exposed to Lavender Essential Oil and Tea Tree Essential Oils.” International Journal of Pediatrics and Adolescent Medicine. 2022;9:117-124. Source.
- Braunstein EW, Braunstein GD. “Are Prepubertal Gynaecomastia and Premature Thelarche Linked to Topical Lavender and Tea Tree Oil Use?” European Endocrinology. 2023;19(2):60-68. Source.
- Hareng L, Kolle SN, Gomes C, Schneider S, Wahl M. “Critical Assessment of the Endocrine Potential of Linalool and Linalyl Acetate: Proactive Testing Strategy Assessing Estrogenic and Androgenic Activity of Lavender Oil Main Components.” Archives of Toxicology. 2024;98(1):347-361. Source.
- Babulka P, Berkes T, Szemerszky R, Köteles F. “No Effects of Rosemary and Lavender Essential Oil and a Placebo Pill on Sustained Attention, Alertness, and Heart Rate.” Flavour and Fragrance Journal. 2017;32(4):305-311. Source.
- Köteles F, Babulka P. “Role of Expectations and Pleasantness of Essential Oils in Their Acute Effects.” Acta Physiologica Hungarica. 2014;101(3):329-340. Source.
- Moss M, Cook J, Wesnes K, Duckett P. “Aromas of Rosemary and Lavender Essential Oils Differentially Affect Cognition and Mood in Healthy Adults.” International Journal of Neuroscience. 2003;113(1):15-38. Source.
- Moss M, Oliver L. “Plasma 1,8-Cineole Correlates with Cognitive Performance Following Exposure to Rosemary Essential Oil Aroma.” Therapeutic Advances in Psychopharmacology. 2012;2(3):103-113. Source.
- Can S, Yildirim Usta Y, Yildiz S, Tayfun K. “The Effect of Lavender and Rosemary Aromatherapy Application on Cognitive Functions, Anxiety, and Sleep Quality in the Elderly with Diabetes.” Explore. 2024;20(6):103033. Source.


